Cargando…

Corrigendum: Lipoxin A4 Inhibits NLRP3 Inflammasome Activation in Rats With Non-compressive Disc Herniation Through the JNK1/Beclin-1/PI3KC3 Pathway

Detalles Bibliográficos
Autores principales:	Jin, Jin, Xie, Yonggang, Shi, Cunxian, Ma, Jiahai, Wang, Yihao, Qiao, Leyan, Li, Kezhong, Sun, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702613/ https://www.ncbi.nlm.nih.gov/pubmed/33312119 http://dx.doi.org/10.3389/fnins.2020.608184

Ejemplares similares

Lipoxin A4 Inhibits NLRP3 Inflammasome Activation in Rats With Non-compressive Disc Herniation Through the JNK1/Beclin-1/PI3KC3 Pathway
por: Jin, Jin, et al.
Publicado: (2020)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

The DHAV-1 protein VP1 interacts with PI3KC3 to induce autophagy through the PI3KC3 complex
por: Li, Juan, et al.
Publicado: (2022)

Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing TXNRD2
por: Zhou, You, et al.
Publicado: (2022)

JNK‐IN‐8 treatment improves ARDS‐induced cognitive impairment by inhibiting JNK/NF‐κB‐mediated NLRP3 inflammasome
por: Shi, Yunchao, et al.
Publicado: (2023)

Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
por: Yang, Chul-Su, et al.
Publicado: (2015)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: a double-blinded, multi-center, randomized study
por: Shi, Cunxian, et al.
Publicado: (2019)

The strategies of NLRP3 inflammasome to combat Toxoplasma gondii
por: Yoon, Chanjin, et al.
Publicado: (2022)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Role of the NLRP3 Inflammasome in Preeclampsia
por: Shirasuna, Koumei, et al.
Publicado: (2020)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

Targeting the NLRP3 Inflammasome in Glaucoma
por: Coyle, Sophie, et al.
Publicado: (2021)

The NLRP3-Inflammasome in Health and Disease
por: Perri, Anna
Publicado: (2022)

An update on the regulatory mechanisms of NLRP3 inflammasome activation
por: Paik, Seungwha, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
por: Guo, Hui-Chen, et al.
Publicado: (2015)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

NLRP3 Inflammasome and Host Protection against Bacterial Infection
por: Kim, Jwa-Jin, et al.
Publicado: (2013)

Kindlin-2 inhibits Nlrp3 inflammasome activation in nucleus pulposus to maintain homeostasis of the intervertebral disc
por: Chen, Sheng, et al.
Publicado: (2022)

Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization
por: Malsy, Jakob, et al.
Publicado: (2020)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
por: Akther, Mahbuba, et al.
Publicado: (2021)

Caspase-11 Interaction with NLRP3 Potentiates the Noncanonical Activation of the NLRP3 Inflammasome
por: Moretti, Julien, et al.
Publicado: (2022)

Role of the Nlrp3 Inflammasome in Microbial Infection
por: Anand, Paras K., et al.
Publicado: (2011)

NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
por: Tavares, Aldo Henrique, et al.
Publicado: (2013)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_malk5gth68v81moccut2tkv6a3